Home > Insider Trading > Filing (0001209191-16-156022)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339970	Atyr Pharma Inc	LIFE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236447	Paul Schimmel	3545 John Hopkins Court, Suite #250 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-09-23	12,572	$0.00	40,440	No	5	G	Direct
Common Stock	Acquisiton	2016-09-23	12,572	$0.00	646,814	No	5	G	Indirect	See Footnote
Common Stock	Acquisiton	2016-12-15	40,000	$2.50	686,814	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2016-12-16	10,000	$2.40	696,814	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	283,581	Indirect	See Footnote

Footnotes

There shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
Represents weighted price for the shares. The shares were purchased at prices ranging from $2.3469 to $2.6411 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
These shares are owned directly by Paul R. Schimmel Prototype PSP. The Reporting Person is the trustee of the Paul R. Schimmel Prototype PSP.